Gideon Schreiber

Overview

Best Publications

• Fundamental aspects of protein-protein association kinetics.

  G. Schreiber;G. Haran;H. X. Zhou

  806
  Citations

• Energetics of protein-protein interactions: Analysis ofthe Barnase-Barstar interface by single mutations and double mutant cycles

  Gideon Schreiber;Alan R. Fersht

  761
  Citations

• Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions

  Susanne A.I. Seidel;Patricia M. Dijkman;Wendy A. Lea;Geert van den Bogaart

  741
  Citations

• Rapid, electrostatically assisted association of proteins

  Gideon Schreiber;Alan R. Fersht

  708
  Citations

• ProMate: a structure based prediction program to identify the location of protein-protein binding sites.

  Hani Neuvirth;Ran Raz;Gideon Schreiber

  553
  Citations

• SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.

  Chihiro Motozono;Mako Toyoda;Jiri Zahradnik;Akatsuki Saito

  542
  Citations

• Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression

  Netanya G. Sandler;Netanya G. Sandler;Steven E. Bosinger;Jacob D. Estes;Richard T R Zhu

  505
  Citations

• PROTEIN-PROTEIN RECOGNITION : CRYSTAL STRUCTURAL ANALYSIS OF A BARNASE-BARSTAR COMPLEX AT 2.0-A RESOLUTION

  Ashley M. Buckle;Gideon Schreiber;Alan R. Fersht

  468
  Citations

• Rational design of faster associating and tighter binding protein complexes

  Tzvia Selzer;Shira Albeck;Gideon Schreiber

  414
  Citations

• Kinetic studies of protein-protein interactions

  Gideon Schreiber

  409
  Citations

• Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons

  Christoph Thomas;Ignacio Moraga;Doron Levin;Peter O. Krutzik

  401
  Citations

• Assessing computational methods for predicting protein stability upon mutation: good on average but not in the details.

  Vladimir Potapov;Mati Cohen;Gideon Schreiber

  394
  Citations

• SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.

  Jiří Zahradník;Shir Marciano;Maya Shemesh;Eyal Zoler

  372
  Citations

• Interaction of barnase with its polypeptide inhibitor barstar studied by protein engineering

  Gideon Schreiber;Alan R. Fersht

  366
  Citations

• The receptor of the type I interferon family.

  G. Uzé;G. Schreiber;J. Piehler;S. Pellegrini

  326
  Citations

• The modular architecture of protein–protein binding interfaces

  D. Reichmann;O. Rahat;S. Albeck;R. Meged

  314
  Citations

• Protein Binding Specificity versus Promiscuity

  Gideon Schreiber;Amy E Keating

  279
  Citations

• Overexpression of the relA gene in Escherichia coli.

  G Schreiber;S Metzger;E Aizenman;S Roza

  261
  Citations

• Inquiring into the Differential Action of Interferons (IFNs): an IFN-α2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN-β

  Diego A. Jaitin;Laila C. Roisman;Eva Jaks;Martynas Gavutis

  257
  Citations

• The molecular architecture of protein–protein binding sites

  Dana Reichmann;Ofer Rahat;Mati Cohen;Hani Neuvirth

  253
  Citations